Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022

Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022

Background In the wake of pandemic‐related health decline and health care disruptions, there are concerns that previous gains for cardiovascular risk factors may have stalled or reversed. Population‐level excess burden of drug‐treated diabetes and hypertension during the pandemic compared with basel...

Full description

Bibliographic Details
Main Authors: Amy Y. X. Yu, Peter C. Austin, Cynthia A. Jackevicius, Anna Chu, Jessalyn K. Holodinsky, Michael D. Hill, Noreen Kamal, Mukesh Kumar, Douglas S. Lee, Manav V. Vyas, Raed A. Joundi, Nadia A. Khan, Moira K. Kapral, Candace D. McNaughton
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
COVID‐19
diabetes
hypertension
pharmacotherapy
time trends
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.034118

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.034118

Similar Items